(Finance) – PharmaNutraa company listed on Euronext STAR Milan and active in the sector of mineral supplements and medical devices for muscles and joints, confirmed the operational start of the American subsidiary PharmaNutra USAincorporated on 12 December 2022.
In particular, it was the operational and commercial structure has been defined of the American company with the opening of the office in Miami (Florida), the appointment of a Country Manager and an Operation Manager, as well as the hiring of a Sales Regional Manager who will coordinate the sales network currently made up of 8 Sales Executives.
At the end of September the entire commercial network was in Italy, at the PharmaNutra headquarters, for a week of scientific training and mutual exchange of knowledge of the markets and their peculiarities. “The first sales made when the sales force returns, testify to the effectiveness of the implemented model“, explains a note.
“The first pieces sold on the American market have a meaning that goes beyond economic valuebut they represent a milestone of the US project – he commented Roberto Lacorte, president of PharmaNutra USA – The sale of the first products follows the enthusiasm we have seen among all members of our American sales force. The structure of Pharmanutra USA is formed, now all that remains is to embark on a growth path based on progressive knowledge of the American market”.